David Ghez
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, COVID-19 Clinical Research Studies, Acute Myeloid Leukemia Research, Adenosine and Purinergic Signaling
Most-Cited Works
- → The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection(2023)17 cited
- → Retrospective analysis of a cohort of 41 <i>de novo</i> B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)(2022)4 cited
- → Novel targeted therapeutics for mantle cell lymphoma – What’s on the horizon?(2015)2 cited
- → Waldenström’s macroglobulinemia: The LYSA pragmatic guidelines(2025)1 cited
- → Prospective monitoring of 591 cancer patients with clonal hematopoiesis detected in daily practice(2025)
- → Sequence Analyses of Relapsed or Refractory Diffuse Large B-Cell Lymphomas Unravels Three Genetic Subgroups of Patients and <i>GNA3</i> Mutant as Poor Prognosis Biomarker, Results of LNH-EP1 Study(2022)
- → Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO)(2022)
- → IL-31: A Potential Implication in CAR T Cells Neurotoxicity?(2023)